Register
Login:
Share:
Email Facebook Twitter


London South East - Oil & Gas Investor Evening: Malcy, Echo, Savannah, SDX
Paul Welch speaks at London South East's Oil & Gas Investor Evening


N4 Pharma Plc Share Price (N4P)



Share Price Information for N4 Pharma Plc (N4P)


Share Price: 5.60Bid: 5.20Ask: 6.00Change: 0.00 (0.00%)No Movement on N4 Pharma Plc
Spread: 0.80Spread as %: 15.38%Open: 5.20High: 5.65Low: 5.20Yesterday’s Close: 5.60

N4 Pharma Plc Ord 0.4P

N4 Pharma Plc is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
5.60
Share Price SpacerBid
5.20
Share Price SpacerAsk
6.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
127,633
Share Price SpacerOpen
5.20
Share Price SpacerHigh
5.65
Share Price SpacerLow
5.20
Share Price SpacerClose
5.60
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 90.96m £5.09m 15,000

52 Week High 35.50 52 Week High Date 19-FEB-2018
52 Week Low 3.35 52 Week Low Date 20-SEP-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
8 37,633 90,000 -1.975 -2.84 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

19-Oct-18
14:33:48
5.296
7,553
Sell* 
5.20
6.00
400.01
Trade Type:
Ordinary

19-Oct-18
13:28:25
5.3112
30,080
Sell* 
5.20
6.00
1,598
Trade Type:
Ordinary

19-Oct-18
11:25:35
5.50
30,000
Sell* 
5.30
6.00
1,650
Trade Type:
Ordinary
Delayed publication




View more N4 Pharma Plc trades >>

Directors Deals for N4 Pharma Plc (N4P)
Trade DateActionNotifierPriceCurrencyAmountHolding
10-Nov-17Buy
Trade Notifier Information for N4 Pharma
Nigel Theobald held the position of CEO at N4 Pharma at the time of this trade.
 Nigel Theobald
7.92GBX56,65612255233
View more N4 Pharma Plc directors dealings >>


mazik
Posts: 1,731
Opinion:No Opinion
Price:5.60
RE: inovio/medimmune
Sat 16:38
Interesting Vander
Vander
Posts: 76
Opinion:No Opinion
Price:5.60
RE: inovio/medimmune
Sat 15:48
If MedImmune announces a deal for an undisclosed amount before end of feb 19 a knowledge of this background helps. Any ongoing connection with MedImmune would be great even if it is for a pittance in return.

Nuvec has to show superiority vs competitors ie other silica nanoparticles or liposomes ( these are already in human trials) or others eg polymers such as pei. Nanoparticle delivery seems better than naked plasmids eg liposomes estimated to better x 20. The nuvec patent which relates to the manufacturing process will be important in defining its point of difference. Nuvec also has quite a lot of data now to back it up, with more on the way
mazik
Posts: 1,731
Opinion:No Opinion
Price:5.60
RE: inovio/medimmune
Sat 14:39
Thank u Vander for sharing your research.
Vander
Posts: 76
Opinion:No Opinion
Price:5.60
inovio/medimmune
Sat 13:09
Medimmune has been testing its HPV DNA vaccine in combination with nuvec for the past 9 months. The details of this has not been widely publicised by NT or others because of commercial sensitivities. The results due in Q4 will be important in defining the potential of nuvec either way

There are over 1000 DNA vaccines listed in trials but only one product, VGX 3100, is in phase3. The results are due 2020. If nuvec partners with the first product to be licensed in a new market, this will boost milestone payments vs a product in phase 1 trials

Here is a 2minute explanation of VGX3100:
https://www.precisionvaccinations.com/vgx-3100-dna-based-immunotherapy

Here is a longer one:
https://globenewswire.com/news-release/2017/06/08/1010247/0/en/Inovio-Begins-Phase-3-Clinical-Trial-of-VGX-3100-for-the-Treatment-of-HPV-Related-Cervical-Pre-Cancer.html

Medimmune is also trialling MEDI0457-a product which includes VGX3100 for head and neck cancer with some positive recent results
There are more complex articles but here is motley fools simple analysis of inovio
https://www.fool.com/investing/2018/10/02/why-inovio-pharmaceuticals-inc-stock-is-soaring-to.aspx

Medimmune and Inovio seem a very long distance from N4P- but who knows?
ccsx
Posts: 84
Opinion:No Opinion
Price:5.60
RE: Significant Shareholders
Fri 17:27
10-Nov-17 Buy Trade Notifier Information for N4 Pharma Nigel Theobald 7.92 GBX 56,656 12255233

This is the state of play at the time of the trade, try the info button next to NT's name, it gives you a clue there.
View more share chat for N4 Pharma Plc (N4P) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.